Aarti Pharmalabs Ltd (AARTIPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003784, "name": "Aarti Pharma", "stock_name": "Aarti Pharma", "full_name": "Aarti Pharmalabs Ltd", "name_url": "stocks-analysis/aarti-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "766.80", "chg": -9.8, "chgp": "-1.26%", "dir": -1, "prev_price": "776.60", "mcapval": "7,035.00 Cr", "mcap": "Small Cap", "scripcode": 543748, "symbol": "AARTIPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0LRU01027", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "1.54 lacs", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-pharma-1003784-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Aarti Pharmalabs Declines 4.83% Amid Mixed Technical Signals: 2 Key Factors This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-declines-483-amid-mixed-technical-signals-2-key-factors-this-week-3982994", "imagepath": "", "date": "2026-05-09 11:01:57", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>4 May:</strong> Intraday high surge to Rs.797.35 (+7.25%)</p>\n <p><strong>5 May:</strong> Strong price rally closing at Rs.805.70 (+8.26%)</p>\n <p><strong>6 May:</strong> Partial recovery to Rs.788.50 (+2.15%)</p>\n <p><strong>7 May:</strong> Decline to Rs.776.60 (-1.51%)</p>\n <p><strong>8 May:</strong> Week closes at Rs.766.80 (-1.26%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.805.70</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</..." }, { "title": "Aarti Pharmalabs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-3981444", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiPharmalabs_mojoScore_3981444.png", "date": "2026-05-08 10:10:44", "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and overall outlook." }, { "title": "Aarti Pharmalabs Ltd Sees Technical Momentum Shift Amid Strong Price Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-sees-technical-momentum-shift-amid-strong-price-rally-3975031", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiPharmalabs_technicaldot_3975031.png", "date": "2026-05-05 08:08:04", "description": "Aarti Pharmalabs Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical trend to a sideways stance, supported by a blend of bullish and bearish signals across key indicators. The stock’s recent surge of 8.26% in a single day to ₹805.70 reflects renewed investor interest, yet technical analysis reveals a complex picture that demands careful scrutiny." }, { "title": "Aarti Pharmalabs Ltd Surges 7.25% to Day's High of Rs 797.35 — Outperforms Sector by 6.42 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-hits-intraday-high-with-725-surge-on-4-may-2026-3974171", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiPharmalabs_priceRelatedfactors_3974171.png", "date": "2026-05-04 14:16:03", "description": "The Sensex gained a modest 0.44% on 4 May 2026, while Aarti Pharmalabs Ltd surged 7.25%, outperforming its Pharmaceuticals & Biotechnology sector by 6.42 percentage points. This sharp single-session advance stands out as a distinctly stock-specific event amid a broadly steady market backdrop." }, { "title": "Aarti Pharmalabs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-3964139", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiPharmalabs_mojoScore_3964139.png", "date": "2026-04-27 10:11:18", "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook." }, { "title": "Aarti Pharmalabs Gains 1.10%: Technical Shift and Financial Challenges Shape Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-gains-110-technical-shift-and-financial-challenges-shape-week-3952166", "imagepath": "", "date": "2026-04-18 11:01:01", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Apr:</strong> Stock opens at Rs.693.75, gains 0.69% despite Sensex decline</p>\n <p><strong>15 Apr:</strong> MarketsMOJO upgrades rating to Sell; stock rises 1.27%</p>\n <p><strong>16 Apr:</strong> Technical momentum shifts; stock dips 0.44% amid mixed signals</p>\n <p><strong>17 Apr:</strong> Week closes at Rs.696.60, down 0.41% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.693.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..." }, { "title": "Aarti Pharmalabs Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3948670", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiPharmalabs_mojoScore_3948670.png", "date": "2026-04-16 08:49:39", "description": "Aarti Pharmalabs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 15 April 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The company’s Mojo Score now stands at 31.0, reflecting a cautious but slightly more favourable outlook amid persistent operational headwinds and valuation considerations." }, { "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-3948438", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiPharmalabs_technicaldot_3948438.png", "date": "2026-04-16 08:08:02", "description": "Aarti Pharmalabs Ltd has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting nuanced changes in key indicators such as MACD, RSI, and moving averages. Despite a modest day gain of 1.10%, the stock’s technical signals present a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Aarti Pharmalabs Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-strong-sell-3933128", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AartiPharmalabs_mojoScore_3933128.png", "date": "2026-04-05 10:10:30", "description": "Aarti Pharmalabs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 April 2026, providing investors with the latest insights into the company’s performance and outlook." } ], "total": 292, "sid": "1003784", "stock_news_url": "https://www.marketsmojo.com/news/aarti-pharmalabs-1003784" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "07-Apr-2026", "details": "Newspaper Advertisement for the Second 100-Day Campaign - Saksham Niveshak", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "07-Apr-2026", "details": "Please find our intimation on captioned subject", "source": "BSE" }, { "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.", "datetime": "04-Apr-2026", "details": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on April 02 2026 for Renil Rajendra Gogri", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aarti Pharmalabs Ltd has declared <strong>30%</strong> dividend, ex-date: 16 Feb 26", "dt": "2026-02-16", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

4 May: Intraday high surge to Rs.797.35 (+7.25%)

5 May: Strong price rally closing at Rs.805.70 (+8.26%)

6 May: Partial recovery to Rs.788.50 (+2.15%)

7 May: Decline to Rs.776.60 (-1.51%)

8 May: Week closes at Rs.766.80 (-1.26%)

Week Open

Rs.805.70

Week CloseRead full news article

Aarti Pharmalabs Ltd is Rated Sell

2026-05-08 10:10:44

Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and overall outlook.

Read full news article

Aarti Pharmalabs Ltd Sees Technical Momentum Shift Amid Strong Price Rally

2026-05-05 08:08:04

Aarti Pharmalabs Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical trend to a sideways stance, supported by a blend of bullish and bearish signals across key indicators. The stock’s recent surge of 8.26% in a single day to ₹805.70 reflects renewed investor interest, yet technical analysis reveals a complex picture that demands careful scrutiny.

Read full news article

Aarti Pharmalabs Ltd Surges 7.25% to Day's High of Rs 797.35 — Outperforms Sector by 6.42 Percentage Points

2026-05-04 14:16:03

The Sensex gained a modest 0.44% on 4 May 2026, while Aarti Pharmalabs Ltd surged 7.25%, outperforming its Pharmaceuticals & Biotechnology sector by 6.42 percentage points. This sharp single-session advance stands out as a distinctly stock-specific event amid a broadly steady market backdrop.

Read full news article

Aarti Pharmalabs Ltd is Rated Sell

2026-04-27 10:11:18

Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

Aarti Pharmalabs Gains 1.10%: Technical Shift and Financial Challenges Shape Week

2026-04-18 11:01:01

Key Events This Week

13 Apr: Stock opens at Rs.693.75, gains 0.69% despite Sensex decline

15 Apr: MarketsMOJO upgrades rating to Sell; stock rises 1.27%

16 Apr: Technical momentum shifts; stock dips 0.44% amid mixed signals

17 Apr: Week closes at Rs.696.60, down 0.41% on the day

Week Open

Rs.693.75

Week Close

Read full news article

Aarti Pharmalabs Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-04-16 08:49:39

Aarti Pharmalabs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 15 April 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The company’s Mojo Score now stands at 31.0, reflecting a cautious but slightly more favourable outlook amid persistent operational headwinds and valuation considerations.

Read full news article

Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-16 08:08:02

Aarti Pharmalabs Ltd has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting nuanced changes in key indicators such as MACD, RSI, and moving averages. Despite a modest day gain of 1.10%, the stock’s technical signals present a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Aarti Pharmalabs Ltd is Rated Strong Sell

2026-04-05 10:10:30

Aarti Pharmalabs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News